Aurinia Pharmaceuticals, Inc. (AUPH)
14.15
-0.06
(-0.42%)
USD |
NASDAQ |
Mar 03, 16:00
14.36
+0.21
(+1.48%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Assets (Quarterly) : 770.59M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 981.67M |
| Oncolytics Biotech, Inc. | 10.82M |
| Edesa Biotech, Inc. | 14.71M |
| Lexaria Bioscience Corp. | 6.051M |
| ProMIS Neurosciences, Inc. | 21.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 189.26M |
| Shareholders Equity (Quarterly) | 581.33M |
| Debt to Equity Ratio | 0.1287 |
| Current Ratio | 5.249 |
| Net Debt Paydown Yield | 0.12% |